Egetis Therapeutics AB (publ) (STO:EGTX)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Emcitate		46.10M	57.60M	21.90M	15.70M	1.73M
Emcitate Growth		-19.97%	163.01%	39.49%	809.09%	-
Common		-	-	600.00K	-	-
PledOx		-	-	-	22.60M	38.94M
PledOx Growth		-	-	-	-41.95%	-52.83%
Total		46.10M	57.60M	22.50M	38.30M	40.66M
Total Growth		-19.97%	156.00%	-41.25%	-5.81%	-50.75%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Japan		-	14.50M	600.00K	22.60M	38.94M
Japan Growth		-	2316.67%	-97.35%	-41.95%	-52.84%
France		6.40M	5.80M	3.90M	2.90M	327.00K
France Growth		10.34%	48.72%	34.48%	786.85%	-
Spain		4.00M	5.00M	3.40M	2.90M	273.00K
Spain Growth		-20.00%	47.06%	17.24%	962.27%	-
Sweden		500.00K	1.30M	1.90M	1.30M	83.00K
Sweden Growth		-61.54%	-31.58%	46.15%	1466.27%	-
Great Britain		600.00K	2.40M	2.50M	2.80M	172.00K
Great Britain Growth		-75.00%	-4.00%	-10.71%	1527.91%	-
Italy		-	2.00M	2.20M	1.00M	-
Italy Growth		-	-9.09%	120.00%	-	-
Poland		1.90M	2.60M	1.70M	700.00K	-
Poland Growth		-26.92%	52.94%	142.86%	-	-
Australia		1.50M	2.50M	1.90M	1.40M	-
Australia Growth		-40.00%	31.58%	35.71%	-	-
Germany		29.40M	16.90M	1.60M	-	-
Germany Growth		73.96%	956.25%	-	-	-
Other Countries		1.70M	4.70M	3.00M	2.50M	872.00K
Other Countries Growth		-63.83%	56.67%	20.00%	186.70%	-
Total		46.00M	57.70M	22.70M	38.10M	40.66M
Total Growth		-20.28%	154.19%	-40.42%	-6.30%	-50.75%

Source: S&P Global Market Intelligence.